IRF
ALNY icon

IBM Retirement Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History

IBM Retirement Fund’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,886
Closed -$308K – 26
2022
Q1 		$308K Sell
1,886
-91
-5% -$13.9K 0.04% 382
2021
Q4 		$335K Sell
1,977
-1,356
-41% -$252K 0.04% 394
2021
Q3 		$629K Buy
3,333
+17
+0.5% +$3.19K 0.05% 344
2021
Q2 		$562K Sell
3,316
-613
-16% -$89.8K 0.04% 386
2021
Q1 		$555K Sell
3,929
-337
-8% -$50.7K 0.04% 411
2020
Q4 		$554K Sell
4,266
-136
-3% -$18.2K 0.04% 415
2020
Q3 		$641K Buy
4,402
+1,075
+32% +$153K 0.06% 298
2020
Q2 		$493K Buy
3,327
+141
+4% +$19K 0.06% 273
2020
Q1 		$347K Buy
3,186
+983
+45% +$113K 0.06% 297
2019
Q4 		$254K Buy
+2,203
New +$220K 0.05% 354
2018
Q3 		– Sell
-2,325
Closed -$229K – 454
2018
Q2 		$229K Sell
2,325
-252
-10% -$25K 0.05% 425
2018
Q1 		$307K Buy
+2,577
New +$332K 0.06% 372
2017
Q1 		– Sell
-6,020
Closed -$225K – 367
2016
Q4 		$225K Sell
6,020
-1,091
-15% -$45.7K 0.01% 862
2016
Q3 		$482K Sell
7,111
-448
-6% -$31.6K 0.02% 644
2016
Q2 		$419K Buy
7,559
+76
+1% +$4.79K 0.02% 729
2016
Q1 		$470K Sell
7,483
-10,545
-58% -$701K 0.02% 679
2015
Q4 		$1.7M Buy
18,028
+2,174
+14% +$202K 0.03% 544
2015
Q3 		$1.27M Sell
15,854
-2,287
-13% -$254K 0.03% 563
2015
Q2 		$2.17M Buy
18,141
+2,422
+15% +$289K 0.04% 459
2015
Q1 		$1.64M Hold
15,719
– – 0.03% 567
2014
Q4 		$1.52M Buy
15,719
+1,451
+10% +$134K 0.03% 576
2014
Q3 		$1.11M Sell
14,268
-1,787
-11% -$115K 0.02% 644
2014
Q2 		$1.02M Buy
+16,055
New +$954K 0.02% 769

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IBM Retirement Fund's ALNY Position: Q2 2022 in Review

IBM Retirement Fund sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2022, closing a stake of 1,886 shares — an estimated $308K sold.

IBM Retirement Fund first reported a position in ALNY in Q2 2014 and held it in 23 quarters. The position peaked at $2.17M in Q2 2015. 421 funds tracked by Wall St. Rank hold ALNY as of Q2 2022.

  • IBM Retirement Fund reported no remaining Alnylam Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 1,886 Alnylam Pharmaceuticals shares in Q2 2022, an estimated $308K.
  • IBM Retirement Fund first reported a position in Alnylam Pharmaceuticals in Q2 2014 and held it in 23 quarters.
  • IBM Retirement Fund's Alnylam Pharmaceuticals position peaked at $2.17M in Q2 2015.
  • 421 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2022.

Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.